Factor XII (HAE) mutation analysis

Definition

The c.983C>A (p.Thr328Lys) variant located in the F12 gene, particularly in exon 9, increases factor XII activity, raising bradykinin production and increasing vascular permeability. It causes HAE type III (HAE-FXII), a form of hereditary angioedema with normal C1 esterase inhibitor levels; the disease predominantly affects women and is markedly influenced by estrogen.

Gene/region examined

FXII - HAE

Method

Sequence analysis

Accepted sample types

EDTA blood, AF, CVS

Inheritance

Hereditary, autosomal dominant (variable penetrance, sex-influenced expression).

Related Tests